Previous Article | Next Article 
Journal of Virology, February 2001, p. 1325-1331, Vol. 75, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1325-1331.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of the Structural Gene Promoter
of Aedes aegypti Densovirus
Todd W.
Ward,
Michael W.
Kimmick,
Boris N.
Afanasiev, and
Jonathan O.
Carlson*
Department of Microbiology, Colorado State
University, Fort Collins, Colorado 80523
Received 14 August 2000/Accepted 10 November 2000
 |
ABSTRACT |
Aedes aegypti densonucleosis virus (AeDNV) has two
promoters that have been shown to be active by reporter gene expression analysis (B. N. Afanasiev, Y. V. Koslov, J. O. Carlson,
and B. J. Beaty, Exp. Parasitol. 79:322-339, 1994). Northern
blot analysis of cells infected with AeDNV revealed two transcripts
1,200 and 3,500 nucleotides in length that are assumed to express the
structural protein (VP) gene and nonstructural protein genes,
respectively. Primer extension was used to map the transcriptional
start site of the structural protein gene. Surprisingly, the structural
protein gene transcript began at an initiator consensus sequence, CAGT, 60 nucleotides upstream from the map unit 61 TATAA sequence previously thought to define the promoter. Constructs with the
-galactosidase gene fused to the structural protein gene were used to determine elements necessary for promoter function. Deletion or mutation of the
initiator sequence, CAGT, reduced protein expression by 93%,
whereas mutation of the TATAA sequence at map unit 61 had little
effect. An additional open reading frame was observed upstream of the
structural protein gene that can express
-galactosidase at a low
level (20% of that of VP fusions). Expression of the AeDNV structural
protein gene was shown to be stimulated by the major nonstructural
protein NS1 (Afanasiev et al., Exp. parasitol., 1994). To determine the
sequences required for transactivation, expression of structural
protein gene-
-galactosidase gene fusion constructs differing in
AeDNV genome content was measured with and without NS1. The presence of
NS1 led to an 8- to 10-fold increase in expression when either genomic
end was present, compared to a 2-fold increase with a construct lacking
the genomic ends. An even higher (37-fold) increase in expression
occurred with both genomic ends present; however, this was in part due
to template replication as shown by Southern blot analysis. These data
indicate the location and importance of various elements necessary for efficient protein expression and transactivation from the structural protein gene promoter of AeDNV.
 |
INTRODUCTION |
Densoviruses are autonomous
parvoviruses that infect arthropods. Aedes aegypti
densonucleosis virus (AeDNV) is in the genus Brevidensovirus
(4, 7). Its 4-kb negative-sense, single-stranded DNA
genome can be divided into two parts, with the nonstructural protein
genes at the left end and the structural protein gene at the right end
(1). AeDNV has two nonstructural proteins, NS1 and NS2,
that are encoded within the same DNA sequence in two different open
reading frames (ORFs). NS1 is required for viral replication and has
been implicated in the transactivation of viral promoters (2,
3). The structural proteins VP1 and VP2 are encoded within the
same ORF (1). VP2 may be a proteolytic cleavage product of
VP1 or the result of a different translation initiation codon.
Brevidensoviruses, like vertebrate parvoviruses, encode all of their
proteins on the same strand (1, 10). Based on the location
of TATAA boxes and ORFs, promoters were previously predicted to be at
map units 7 and 61 for the nonstructural and structural genes of AeDNV,
respectively (1, 2). These regions are conserved between
AeDNV, Aedes albopictus parvovirus (AaPV), and a new isolate from mosquito cells (1, 10; B. N. Afanasiev, unpublished observations).
Extensive study of parvovirus promoter structure and transcriptional
regulation has been mainly confined to the mammalian parvoviruses
(10). These viruses use alternative splicing to yield
different coterminal transcripts from the same promoter (for a review,
see reference 8), which increases the number of protein
species produced. Core promoter elements, which have been found to
include a TATAA element and an upstream SP1 binding site
(21), are sensitive to the presence of the viral NS1
protein (14, 17, 26, 30). However, the core promoter
structure of densoviruses is not well defined. A parvovirus of
cockroaches (Periplaneta fuliginosa DNV), of the genus
Densovirus, is likely to utilize alternative splicing
(31), but it is not clear whether members of the genus
Brevidensovirus or Iteravirus do so as well. Some
indirect evidence does suggest that AeDNV and members of the
Densovirus genus can initiate translation at multiple AUG codons to produce multiple proteins from the same transcript (7, 17). Promoters of baculoviruses, another family of arthropod viruses, have been studied intensively. Early genes have been found to
utilize TATAA sequences and an initiator sequence CAGT (9,
25). Late genes are expressed using a viral polymerase that
initiates transcription at a TAAG sequence (9, 23, 25). The CAGT motif of the early genes can function without an accompanying TATAA sequence (9, 23, 25). This CAGT sequence has been shown to be important for expression from many arthropod and mammalian promoters whether or not they contain a TATAA sequence (9, 11,
27). This CAGT motif is observed downstream of TATAA sequences of both putative promoter regions of AeDNV.
This report presents analysis of expression from the structural protein
gene promoter of AeDNV. We used Northern blot analysis to identify RNA
species production and primer extension to map the transcription start
site for the structural gene. Deletion analysis and site-directed
mutagenesis were used to identify structural gene promoter sequence
elements, and the sequences required for transactivation were also investigated.
 |
MATERIALS AND METHODS |
Cloning and mutagenesis.
All plasmid clones were grown in
Escherichia coli DH5-
cells. pUCA, the infectious clone
of the AeDNV genome, is described in detail elsewhere (2).
pUCAINV is the transactivating construct used to supply NS1 without VPs
(2). nsp61gal was derived from pUCA by inserting the
lacZ gene in frame with the VPs at the SnaBI site
at nucleotide 2674 as described elsewhere (2). pVPNco contains virus sequences from nucleotides 2043 to 2674 including the
structural gene promoter driving expression of the
VP-
-galactosidase fusion protein. This was accomplished by deleting
the left end of the virus from nsp61gal by ligating Klenow
enzyme-filled SstI and NcoI restriction digested
nsp61gal DNA. This left 420 nucleotides of virus sequence upstream from
the p61 TATA sequence. The right-hand terminal sequences were deleted
by digestion with HindIII followed by religation.
pVPFsp is identical to pVPNco but with only 83 nucleotides
(2381 to 2674) upstream of the p61 TATA sequence. pVPMsc is
identical to pVPFsp but contains only 24 nucleotides (2440 to 2674)
upstream of the p61 TATA sequence to the MscI site. This was
created by digesting nsp61gal with MscI and religating to
create a p7-p61 fusion. The p7 sequence was deleted by digestion with
MscI and NarI, filling in with Klenow polymerase
and ligation.
Fsp/Msc is identical to pVPNco but with a deletion
of nucleotides 2381 to 2440. This was created by digestion with
MscI and partial FspI digestion to remove the
region of interest, followed by Klenow polymerase repair of the
FspI cohesive end and ligation. pATG.1 is a fusion of the
lacZ gene to the first ATG in the structural gene
transcript. It was made by partial BamHI digestion of
pVPNco followed by MscI digestion, mung bean nuclease
treatment, gel isolation of the 5,500-bp fragment, and ligation. This
removes the region between the VP-LacZ fusion and the first ATG.
pVPNcoRLE is pVPNco with the right and left ends (5' and 3'
nucleotides 1 to 268 and 3736 to 3999, respectively) of the virus
left
intact. It was made by digestion of nsp61gal with
EcoNI and
NcoI. These overhangs were filled in with Klenow enzyme and
ligated.
pVPNcoRE is pVPNco with the right end of the virus
still intact.
It was created by digestion of nsp61gal with
NarI and
NcoI; these
ends were filled in with
Klenow enzyme and ligated. pVPNcoLE is
pVPNco with the left end
of the virus intact. It was created by
digestion of pVPNcoRLE with
HindIII and
religation.
For PCR mutagenesis, primers flanking the region of interest
(structural gene region nucleotides 2045 to 2674) were synthesized
(Gibco BRL, Gaithersburg, Md.). Primer Kasfwd
(CAGATGCGTAAGGAGAAAATACCGC)
binds to pUC sequences upstream
of the region of interest. Primer

galrev (GTTGTAAAACGACGGGATCC)
binds to

-galactosidase sequences
120 nucleotides downstream
from the VP-LacZ
fusion.
To create mutations, two complementary primers were designed with a
diagnostic restriction enzyme recognition site at the
desired location.
Two separate PCRs (one with Kasfwd and the mutation
reverse primer and
one with

-galrev and the mutation forward
primer) were performed to
yield two fragments with the mutation
at either end. These fragments
were purified from 1% agarose gel
using a GeneClean kit (Bio 101, La
Jolla, Calif.). Purified fragments
were mixed together and denatured at
95°C for 10 min and allowed
to anneal by cooling to 45°C for 10 min.
Taq polymerase and deoxynucleoside
triphosphates were
then added, and the mixture was incubated for
10 min at 72°C.
Finally, 10.5 pmol of the flanking primers was
added, and the mixture
was cycled 29 times at 95°C for 1 min,
45°C for 1 min, and 72°C
for 2.5 min. To mutate the map unit 61
TATATAA sequence (designated
p61), two complementary primers were
made with a
DraI
restriction site (underlined) at nucleotide 2470
(CACAAAAA
TTTAAAATCTAATAGCAGAAGAAG
[point mutations
in bold]). For mutation of the map unit 60 TATAA sequence, complementary
primers with an
XhoI
restriction sequence
(GACAATATAC
CTCGAGTGCGCAAATAC)
in the map unit 60 TATA sequence were used. For mutation of the
transcription start site sequence, complementary primers with
an
EcoRV restriction sequence
(CAAAATAAATTA
GATATCCGTCCTCCAACTC)
within the consensus start sequence were used. Fragments with
these mutations were cut with
NarI and
BamHI and
inserted into
the pVPNco

gal subclone digested with the same
enzymes. Successful
insertions were then cut with
BamHI, and
the
lacZ gene was added.
The
lacZ gene was
obtained from nsp61gal digested with
BamHI (3,072-bp
fragment). All mutations were confirmed by sequencing using an
automated sequencer at Colorado Sate University or the University
of
Colorado.
Cells and transfections.
For transfection, A. albopictus C6/36 cells were grown in L15 medium with 10% fetal
bovine serum at 25°C in six-well plates at a density of 1.6 × 106 cells/well (17). Eighteen hours later, the
cells were rinsed twice with phosphate-buffered saline (PBS) and 150 µl of the transfection mixture was added. The transfection mixture
was made by combining 5 µg of plasmid DNA in 50 µl of L15 (3 µg
of
-galactosidase expression construct, 1.5 µg of transactivating
construct or pUC19, and 0.5 µg of pBSLuc) with 100 µl of L15-20%
Lipofectin reagent (Gibco BRL). Cells were then incubated at 28°C for
6 h. The transfection mixture was removed, the cells were rinsed
twice with PBS, and fresh complete L15 medium was added.
Protein expression assays.
At 48 h posttransfection,
cells were rinsed twice with sterile PBS, lysed, and harvested using a
Galactolight kit (Tropix, Bedford, Mass.).
-Galactosidase expression
was quantified by incubating 5 µl of a 1:10 dilution of the cell
lysates with Galacton reagent (Tropix) and measuring the resulting
reaction with a TD-20e luminometer (Turner Designs, Sunnyvale, Calif.)
as described previously (3, 17). Luciferase levels were
determined using a luciferase assay system (Promega, Madison, Wis.) and
TD-20e luminometer. Arbitrary light units from the
-galactosidase
assays were normalized to the average light units of luciferase, which
controls for transfection and lysis efficiency. Lysates from
nontransfected C6/36 cells were included as a negative control.
Northern blot analysis.
Poly(A)+ RNA from both
uninfected and infected C6/36 cells was isolated from total RNA
(17). A 10-ml Poly Prep chromatography column (Bio-Rad,
Richmond, Calif.) was washed with 10 ml of 5 M NaOH and then with 10 ml
of diethyl pyrocarbonate-treated water. Dry oligo(dT)-cellulose powder
(0.125 g) was suspended in 250 µl of 0.1 M NaOH, and the slurry was
poured into the column. The oligo(dT) column was equilibrated with 10 ml of poly(A) loading buffer (0.5 M LiCl, 10 mM Tris-Cl [pH 7.5], 1 mM EDTA, 0.1% sodium dodecyl sulfate [SDS]). Then 200 µg of total
RNA dissolved in 0.5 M LiCl was heated to 70°C for 10 min and passed
through the column. The column was washed, and the poly(A)+
RNA was eluted in 500 µl of 2 mM EDTA-0.1% SDS. The RNA was then precipitated overnight with 0.3 M sodium acetate and 2 volumes of
ethanol at
20°C and centrifuged at 233,800 × g and
4°C for 1 h. The supernatant was decanted, and the pellet was
allowed to air dry. RNA was dissolved in 100 µl of diethyl
pyrocarbonate-treated water.
Two plasmids, pBluA and pBluA2, were constructed for transcribing
hybridization riboprobes specific to structural and nonstructural
genes
of AeDNV, respectively. pBluA was made by cloning the 4,000-bp
SstI/
XhoI fragment from pUCA (
2)
into the like sites of pBluescript
(Stratagene, La Jolla, Calif.).
pBluA2 was made by removing the
2,800-bp
BamHI fragment from
pBluA.
SnaBI and
EcoRI were used
to linearize
pBluA and pBluA2, respectively, and were transcribed
with T3 RNA
polymerase (Promega). This yields a 1,186-nucleotide
transcript that
will hybridize to the structural gene transcripts
(nucleotides 2792 to
3978) and a 900-nucleotide transcript that
will hybridize to the
nonstructural gene transcripts (nucleotides
307 to
707).
After gel electrophoresis using an garose-formaldehyde gel
(
17), the poly(A)
+ RNA was transferred to a
MagnaGraph nylon transfer membrane (Micron
Separations Inc., Wesboro,
Mass.). Probes were hybridized overnight
at 45°C in hybridization
buffer (50% formamide, 6× SSPE [1× SSPE
is 0.18 M NaCl, 10 mM
NaH
2PO
4, and 1 mM EDTA {pH 7.7}], 5×
Denhardt's
solution, NS or VP probe [10
6 cpm]).
Membranes were washed twice in 2× SSC (1× SSC is 0.15
M NaCl plus
0.015 M sodium citrate)-0.2% SDS at 50°C for 1 h.
Images were
captured by exposing the blots to a PhosphorImager
screen (Molecular
Dynamics, Sunnyvale, Calif.) overnight. The
captured images were
digitized and imported into NIH Image 1.6
for densometric
analysis.
Primer extension analysis.
A 10.5-pmol aliquot of
oligonucleotide was labeled with [
-32P]ATP using T4
polynucleotide kinase as recommended by the manufacturer (New England
Biolabs, Beverly, Mass.). Oligonucleotide
galrev (CCTAGGGCAGCAAAATGTTG) binds to the 5' end of the
lacZ gene just downstream from the BamHI site.
p61rev108 (GGTACTGCCTCTTGTTGCT) binds to the viral sequence
108bp downstream from the p61 TATA at nucleotides 2583 to 2604.
galrev and p61rev108 were used for primer extension on total RNA
from cells transfected with nsp61gal and pUCA, respectively. RNA
harvested from nontransfected C6/36 cells was used as a negative
control. C6/36 cells were transfected as above except that
75-cm2 flasks seeded with 2.25 × 107
cells were incubated with 800 µl of transfection mixture (150 µl of
Lipofectin and 30 µg of plasmid DNA in L15). Total RNA was collected
from cells transfected as above by the guanidinium isothiocyanate method (17, 18) or by passage through an RNeasy spin
column (Qiagen, Valencia, Calif.). RNA was aliquoted in 30-µg
samples, treated with 100 U of DNase (Gibco BRL) for 30 min,
precipitated with 2 volumes of ethanol and 0.1 volume of 3 M sodium
acetate, and washed twice with 70% ethanol. The RNA was then
resuspended in 12.5 µl of hybridization buffer (final concentration,
150 mM KCl, 10 mM Tris-HCl [pH 8.3], 1 mM EDTA); 0.8 pmol of labeled probe was added and allowed to anneal for 30 min at 65°C after being
denatured for 5 min at 95°C. Primer extension buffer was added (final
concentration, 50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol) with 10,000 U of Superscript AMVRT (Gibco BRL). The reaction mixture was incubated at 42°C for 50 min, and the reaction was stopped by heating to 70°C for 10 min. Then
4 µl of gel loading/stop buffer was added (New England Biolabs), and
the samples were denatured at 95°C for 10 min and separated on a 5%
acrylamide-8 M urea sequencing gel at 1,500 V for 2.5 h. To
determine the precise transcriptional start site, sequencing was
performed on nsp61gal or pUCA as a template with the same
oligonucleotides as used for primer extension, using a Circumvent
sequencing kit (New England Biolabs). These sequencing ladders were
denatured as above and loaded next to the primer extension products for
visualization of the transcriptional start site. Gels were then
transferred to Whatman filter paper and dried. Gels were visualized by
autoradiography using Fuji medical X-ray film (Fuji Medical Systems,
Stamford, Conn.) for 5 to 72 h at
70°C.
Replication analysis.
C6/36 cells (7.5 × 106) were transfected with constructs containing the VP
promoter and viral ends; 48 h posttransfection, low-molecular-weight DNA was extracted by the Hirt method
(1). The DNA was precipitated with 10 M ammonium acetate
and ethanol, washed twice with 70% ethanol, and resuspended in 50 µl
of water. Each sample was digested with DpnI overnight at
37°C. The enzyme was heat killed; then the samples were loaded onto a
1% agarose gel and run for 6 h at 40 V. The DNA was transferred
to a GeneScreen Plus membrane (DuPont), which was then prehybridized
(50% formamide, 10% dextran sulfate, 2× SSC, 10% SDS) for 1 h
at 45°C. Probe was prepared by random prime labeling (Boehringer
Mannheim, Indianapolis, Ind.) a 3,072-bp lacZ gene fragment
obtained by digesting nsp61gal with BamHI and purifying the
3,072-bp fragment by using agarose gel electrophoresis and a GeneClean
kit (Tropix); 107 dpm of probe was hybridized to the
membrane in 4.5 ml of hybridization buffer (50% formamide, 10%
dextran sulfate, 2× SSC, 10% SDS) for 12 h at 45°C. The
membrane was then washed twice with 2× SSC for 10 min and visualized
by autoradiography using Fuji medical X-ray film (Fuji Medical Systems)
for 5 to 72 hours at
70°C.
 |
RESULTS |
AeDNV mRNA species.
Northern blot analysis was performed to
determine the size and relative abundance of viral RNA species present
within AeDNV-infected cells. NS and VP probes that would hybridize to
the NS1/NS2 transcript and the VP transcript, respectively, were
generated. As shown in Fig. 1, two
distinct transcripts of about 3,500 and 1,200 nucleotides were
detected. The NS probe hybridized with the 3,500-nucleotide transcript.
The VP probe bound to both transcripts, indicating that the longer
transcript contains both NS and VP sequences. These transcripts
correspond well to the expected sizes of the nonstructural and
structural gene transcripts, respectively, assuming that both terminate
at the same polyadenylation signal predicted near the right end of the
viral genome (1). Quantification of the signal indicated
that the VP transcript (1,200 nucleotides) is 2.2 times more abundant
than the NS transcript.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 1.
Northern blot of poly(A) RNA from C6/36 cells infected
with AeDNV (lanes I) or uninfected (lanes U). Membranes were probed
with NS (A)- and VP (B)-specific probes. nt, nucleotides.
|
|
Structural gene transcript initiation site.
Primer extension
analysis was used to precisely map the initiation site for the
structural gene transcript. Primers that bound either to viral
sequences (p61rev108) or to the 5' end of the lacZ reporter
gene (
galrev) 108 or 200 nucleotides downstream from the map unit 61 TATAA sequence were used. LacZ fusions were included to confirm the
identity of the transcription start site of reporter gene constructs,
and the results were identical to those for the AeDNV-infected cells.
As shown in Fig. 2a, when the
32P-labeled p61rev108 oligonucleotide was extended by
reverse transcriptase, we observed a band approximately 200 nucleotides
in length that corresponds to nucleotide 2402, which is 60 nucleotides
upstream of the map unit 61 TATAA sequence. The putative start site is the first C within the sequence TCAGTC. Primer
galrev (Fig. 2b) also
mapped the transcript initiation to the C in the CAGT site, using
nsp61gal-transfected cellular RNA.

View larger version (108K):
[in this window]
[in a new window]
|
FIG. 2.
Primer extension analysis of the structural gene
transcript (sequence reads from top to bottom). (a) Primer extension
using virus-specific primer p61rev108. Lanes T, A, G, and C, sequencing
ladder produced using nsp61gal and primer p61rev108; lane 1, RNA from
cells transfected with VP-LacZ fusion construct nsp61gal; lane 2, RNA
from cells infected with AeDNV. (b) Primer extension using
lacZ gene-specific primer galrev. Lanes T, A, G, and C,
sequencing ladder produced using nsp61gal and primer galrev; lane 1, RNA from cells transfected with VP-LacZ fusion construct nsp61gal; lane
2, RNA from nontransfected cells.
|
|
Mutational analysis of the structural gene promoter.
To
determine the sequences critical for expression of the structural gene,
different constructs containing the lacZ reporter gene fused
to the VP reading frame at nucleotide 2674 (2) were compared for the efficiency of
-galactosidase expression. These constructs contained deletions of the viral sequences upstream of
the VP gene. Plasmid constructs pVPMsc, pVPFsp, and
pVPNco contain 24, 83, and 420 bp, respectively, upstream of the
map unit 61 TATAA (Fig.
3). The level of
expression from pVPNco was arbitrarily set to 100%. pVPFsp
contains the initiation site defined by primer extension but
lacks a TATAA sequence at map unit 60, 26 nucleotides upstream of
the initiation site. This construct expressed at 30% of the level of
pVPNco. pVPMsc lacks the initiation site and did not express
above the background level.
Fsp/Msc has a deletion of the 60 nucleotides between the FspI and MscI sites
(nucleotides 2381 to 2440) including the initiator (Inr) site, no
-galactosidase expression was detected from this construct. This
suggested that the region containing the Inr site is critical for
expression. Fusion of the lacZ gene to the first ATG codon in the transcript, which is not in the VP reading frame (Fig. 3a,
pATG.1), reduced expression by 80%.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
(a) Effects of deletions and mutations on
VP- -galactosidase ( -gal) fusion protein expression. The
VP- -galactosidase fusion is indicated by black boxes with the
relative upstream deletions or mutations indicated. The mutated
sequences are shown below the wild-type viral sequence. Relative expression levels
represent three experiments performed in duplicate and are normalized
to the -galactosidase expression of pVPNco. The dotted box
(pATG.1) represents -galactosidase fused to the first AUG of the
transcript. AUG1, the first AUG in the VP transcript which
is not in frame with the VP ORF; AUG2, AUG for the VP ORF.
(b) Sequence of the VP promoter region (nucleotides 2372 to 2563).
|
|
To test their importance, the CAGT, map unit 60 TATAA, and map unit 61 TATAA sequences were modified via PCR-based mutagenesis.
Changing the
map unit 60 TATAA from TATAA to CTCGA reduced expression
by 60% (Fig.
3,

p60) compared to the wild-type construct pVPNco.
Two
nucleotide changes, T to A and A to T, in the map unit 61
TATATAA
sequence were made yielding the sequence TTTAAAA. These
changes were
chosen because the region surrounding this sequence
is very AT rich,
with only five GC base pairs within 25 nucleotides.
This mutation did
not have a significant effect on expression
of the

-galactosidase
fusion protein (93% of that of pVPNco).
The most dramatic
reduction in expression was seen when the sequence
surrounding the
transcriptional start site was changed. A four-nucleotide
change from
TCAGTC to ATATCC (Fig.
3,

INR) reduced expression
by 93% compared
to pVPNco. This reduction is similar to the reduction
observed with

Fsp/Msc, in which the CAGT sequence and the surrounding
60 nucleotides are
deleted.
Requirements for transactivation.
It has been reported that
both of the AeDNV promoters can be transactivated by NS1 (2, 3,
17). The construct pVPNco was relatively insensitive to the
presence of NS1 (provided by pUCAINV), it exhibited a 1.7-fold
increase, compared to constructs studied previously that showed a
7-fold increase in gene expression (2; unpublished observations). Since
NS1 is thought to interact with the terminal sequences of the viral
genome, the 5'- and 3'-terminal sequences were added back to
pVPNco. Constructs containing the right (5') end (pVPNcoRE),
left (3') end (pVPNcoLE), or both ends (pVPNcoRLE) were
transfected into C6/36 cells and analyzed for expression of
-galactosidase in the presence and absence of the transactivating
construct pUCAINV. All four constructs had similar basal levels of gene
expression without pUCAINV (Table 1).
However, expression from the constructs containing viral terminal
sequences was greatly enhanced by cotransfection with pUCAINV.
pVPNcoRE and pVPNcoLE had increases of 9.7- and 7.9-fold,
respectively, whereas pVPNcoRLE showed a 37-fold increase
in
-galactosidase expression (Table 1). These results demonstrate
that viral termini are necessary for increased expression from the
structural gene promoter when NS1 is present.
Since NS1 is involved in both the transactivation of parvovirus
promoters and the replication of viral genomes (
16,
30),
we sought to differentiate between increased gene expression due
to
transactivation and replication of the template. Low-molecular-weight
DNA was extracted from cells transfected as above with the construct
pVPNco, pVPNcoRE, pVPNcoLE, or pVPNcoRLE with and
without pUCA.
This DNA was then digested with
DpnI, which
cleaves all Dam-methylated
GATC sites in DNA of bacterial origin while
leaving unmethylated
viral replicative form DNA intact. These samples
were analyzed
by Southern blotting. The membrane was probed with
a
lacZ gene-specific
probe to detect any
replicated construct DNA. When both viral
ends were present
(pVPNcoRLE), a 4.6-kb,
DpnI-resistant band was
observed
in the presence of NS1, indicating replication of the
construct (Fig.
4, lane 8). Other constructs lacking
either or
both ends only show
DpnI digestion fragments.
Thus, the increase
in protein expression observed when both viral ends
and NS1 were
present is due to both template replication and
transactivation
by NS1. This is consistent with previous observations
with AeDNV
and other parvoviruses (
2,
16,
26).

View larger version (139K):
[in this window]
[in a new window]
|
FIG. 4.
Replication analysis of -galactosidase
expression constructs. Southern blot of Hirt extracts from C6/36 cells
digested with DpnI after transfection as follows: with lane
1, pVPNco; lane 2, pVPNco plus NS1; lane 3, pVPNcoRE; lane
4, pVPNcoRE plus NS1; lane 5, pVPNcoLE; lane 6, pVPNcoLE
plus NS1; lane 7, pVPNcoRLE; lane 8, pVPNcoRLE plus NS1.
The blot was probed with a 32P-labeled lacZ
gene-specific probe.
|
|
 |
DISCUSSION |
Previous studies have shown the existence of two functional
promoters within the AeDNV genome, which were designated p7 and p61
according to the location of suspected TATAA boxes (1-3). In support
of these observations, Northern blot analysis detected the presence of
two RNA transcripts (Fig. 1). The smaller transcript exhibited a size
(1,200 nucleotides) that corresponded well to the expected length of
the structural protein gene transcript and hybridized only to a VP
probe. The larger (3,500-nucleotide) transcript hybridizes to both VP
and NS probes. This implies that it is expressed from the p7 promoter,
bypasses the previously proposed polyadenylation site at the end of the
NS1 gene (nucleotide 2730) (1), and uses the same
polyadenylation site as the structural gene transcript (nucleotide
3679). This type of transcriptional organization in which all
transcripts terminate at a polyadenylation signal near the right end of
the genome is common among parvoviruses with the exception of B19 and
members of the Densovirus genus (7, 8).
By using primer extension analysis, the transcriptional initiation site
of the structural gene promoter was mapped to nucleotide 2402. It is
located within a consensus Inr sequence TCAGTC, with the first C being
+1. This Inr sequence fits the consensus Inr (TCA[G/T]T[T/C])
sequence of arthropods, including Drosophila, except the +1
is at the C and not A position. This motif is common in baculoviruses,
arthropods, and mammalian systems (11, 23, 25, 27). The
Inr is 60 nucleotides upstream of the TATAA sequence previously assumed
to define the VP promoter (p61) (1, 2, 10). Deletions
which encompass the Inr region (Fig. 3a,
Fsp/Msc and pVPMsc),
but retain the putative p61 TATAA sequence, severely crippled gene
expression. Mutation of the putative p61 TATAA sequence (
p61) had an
insignificant effect on gene expression (Fig. 3a). Thus, the p61
TATAA sequence does not seem to be involved in gene expression. A
different TATAA sequence located upstream of the transcriptional start
site, at nucleotide 2373, and the Inr were mutated by PCR mutagenesis
to confirm their function. A four-nucleotide change in the Inr sequence
(
INR) resulted in a 93% reduction of gene expression (Fig. 3a). The
TATAA sequence upstream of the Inr was found to be less important since
constructs retained 30% (pVPFsp) to 40% (
p60) of expression
with this sequence deleted or mutated, respectively (Fig. 3a). These
observations together place the dispensable TATA box of the structural
gene promoter at nucleotide 2372 and demonstrate that the consensus Inr
sequence, CAGT, is critical for efficient gene expression. This
requirement of an Inr sequence for gene expression with a TATAA
sequence only enhancing expression has been observed with a variety of
Drosophila and mammalian genes, as well as baculovirus
genes, containing the consensus sequence CAGT (9, 11, 23, 27,
28). Baculovirus early genes contain this Inr sequence
(23), which is known to interact with cellular
transcription factors such as TFIID (28) and would also be
required for expression of densovirus genes which rely on cellular
transcription machinery. In contrast, baculovirus late genes utilize a
baculovirus-specific polymerase that recognizes the sequence TAAG and,
with rare exceptions, lack a functional CAGT motif (23,
25).
Interestingly, with transcription beginning at nucleotide 2402, there
is a short ORF starting 125 nucleotides upstream of the putative
initiation codon of the VP gene (Fig. 3b). If expressed, this ORF would
produce an 80-amino-acid protein corresponding to the carboxy terminus
of the viral NS1 protein and could interfere with translation of the VP
gene. A lacZ gene fusion to this upstream AUG (pATG.1) was
expressed, though at a much relower level than VP fusions (Fig. 3a).
The context of an AUG codon is important for the efficiency of
translation initiation at that site, the optimal context being
(A/G)CCAUGG (19). The context surrounding the
AUG of the small ORF at nucleotide 2440 (CATAUGG) has a
four-of-seven match to that of the optimal sequence (19).
However, the first AUG in the VP reading frame (ATCAUGG) is
more optimal, having matches of six of seven nucleotides. These
observations may explain the reduced level of expression of the small
ORF and the robust translation of the structural proteins from the
downstream AUG (20). The sequences surrounding these AUG
codons, the Inr, and the TATA box are completely conserved between
AeDNV, AaPV, and a newly isolated mosquito DNV (1, 10;
unpublished observations), suggesting that they are important for
regulation of gene expression. It is interesting that the feline
panleukopenia parvovirus and B19 virus were shown to contain one and
many AUG codons, respectively, upstream from the structural gene AUG
(13, 24). Deletion of these upstream AUG triplets resulted
in increased gene expression, supporting the theory that a scanning
ribosome was leaking past the first AUG to produce structural proteins.
The presence of an upstream ORF may be another method of fine-tuning
viral protein expression within infected cells, and may affect the
pathogenesis of parvovirus diseases (12). It is
interesting that expression of the NS2 protein of AeDNV would also
require the ribosome to miss the NS1 start codon and scan further to
translate this protein or perhaps to initiate via an internal ribosome
entry site (17). Detailed examination of translation
initiation will be required to elucidate the true function, if any, of
the small ORF.
AeDNV promoters are known to be affected by the viral NS1 protein
(2, 3). Expression from the base construct
pVPNco, which lacks either of the viral ends, was found in
this study to be relatively insensitive to stimulation by NS1 (1.7-fold
[Table 1]). This is in contrast to previous work, which showed that the structural protein gene promoter can be transactivated by NS1
(2). However, the constructs used in the previous study contained the left end of the viral genome, which in many parvovirus systems is known to interact with NS1 (14, 15, 30). To
determine the effect of the viral genome termini on transactivation of
the structural protein gene promoter, the virus terminal sequences were
added back to the pVPNco construct. Adding either the right or the
left end had a dramatic effect on expression in the presence of NS1,
increasing expression 9.7- or 7.9-fold with the right or left end,
respectively (Table 1). This is in contrast to what has been found with
minute virus of mice and feline panleukopenia virus, where sequences
proximal to the viral promoter are fully functional in transactivation
by NS1 without the viral ends (13, 21, 22). It remains
possible that viral sequences other than the termini affect
transactivation, since sequences of the VP gene and between the viral
left end and the NcoI site were not tested. NS1 of other
parvoviruses have been shown to bind sequences in the viral terminal
regions (14-16, 30). This may indicate the presence of an
enhancer-like sequence in the AeDNV viral ends similar to those
observed under certain conditions for adeno-associated virus type 2 (6). The addition of both viral ends had a synergistic effect above that of either end alone, with a 37-fold increase in
expression in the presence of NS1 (Table 1). Similar observations were
made with the p4 promoter of the LUIII parvovirus (16). This is to be expected because the viral ends allow excision from the
plasmid and subsequent replication of flanked sequences
(2). Southern blot analysis (Fig. 4) confirms that
replication of the viral DNA does indeed take place, provided that both
viral ends and NS1 are present. Thus, the increase in template number
was at least partially responsible for the greater increase in
transactivated expression levels of pVPNcoRLE over constructs
containing only one viral end. It is not clear whether both viral ends
can produce a greater enhancer effect or if replication accounts for
the entire increase in gene expression in the presence of NS1.
It is obvious from this study that although AeDNV has one of the
smallest of DNA virus genomes, much can be learned from it that may
apply to other mosquito densovirus promoters and add to a deeper
understanding of gene expression and regulation in mosquitoes.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the National Institutes of
Health (NIAID AI25629, AI28781, and AI46793) and the John D. and
Catherine T. MacArthur Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Colorado State
University, Department of Microbiology, Fort Collins, CO 80523. Phone: (970) 491-7840. Fax: (970) 491-1815. E-mail:
jcarlson{at}cvmbs.colostate.edu.
Present address: 512 Pike Ave., Canon City, CO 81212.
 |
REFERENCES |
| 1.
|
Afanasiev, B. N.,
E. E. Gaylov,
L. P. Buchatsky, and Y. V. Kozlov.
1991.
Nucleotide sequence and genomic organization of Aedes densonucleosis virus.
Virology
185:323-336[CrossRef][Medline].
|
| 2.
|
Afanasiev, B. N.,
Y. V. Kozlov,
J. O. Carlson, and B. J. Beaty.
1994.
Densovirus of Aedes aegypti as an expression vector in mosquito cells.
Exp. Parasitol.
79:322-339[CrossRef][Medline].
|
| 3.
|
Afanasiev, B. N.,
T. W. Ward,
B. J. Beaty, and J. O. Carlson.
1999.
Transduction of Aedes aegypti mosquitoes with vectors derived from Aedes densovirus.
Virology
257:62-72[CrossRef][Medline].
|
| 4.
|
Afanasiev, B. N., and J. Carlson.
2000.
Densovirinae as gene transfer vehicles, p. 33-58 S.
In
S. Faisst, and J. Rommelaere (ed.), Parvoviruses: from molecular biology to pathology and therapeutic uses. S. Karger, Basel, Switzerland.
|
| 5.
|
Bando, H.,
J. Kusuda,
T. Gojobori,
T. Maruyama, and S. Kawase.
1987.
Organization and nucleotide sequence of a densovirus imply a host-dependent evolution of the parvoviruses.
J. Virol.
61:553-560[Abstract/Free Full Text].
|
| 6.
|
Beaton, A.,
P. Palumbo, and K. I. Berns.
1989.
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein.
J. Virol.
63:4450-4454[Abstract/Free Full Text].
|
| 7.
|
Bergoin, M., and P. Tijssen.
2000.
Molecular biology of densoviruses, p. 12-32.
In
S. Faisst, and J. Rommelaere (ed.), Parvoviruses: from molecular biology to pathology and therapeutic uses. S. Karger, Basel, Switzerland.
|
| 8.
|
Berns, K. I.
1996.
Parvoviridae: the viruses and their replication, p. 2173-2197.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fundamental virology, 3rd ed. Lippincott-Raven Publishers, Philidelphia, Pa.
|
| 9.
|
Blissard, G. W.,
P. H. Kogan,
R. Wei, and G. F. Rohrmann.
1992.
A synthetic early promoter from a baculovirus: roles of the TATA box and conserved start site CAGT sequence in basal levels of transcription.
Virology
190:783-793[CrossRef][Medline].
|
| 10.
|
Boublik, Y.,
F. Jousset, and M. Bergoin.
1994.
Complete nucleotide sequence and genomic organization of the Aedes albopictus parvovirus (AaPV) pathogenic for Aedes aegypti larvae.
Virology
200:752-763[CrossRef][Medline].
|
| 11.
|
Cherbas, L., and P. Cherbas.
1993.
The arthropod initiator: the capsite consensus plays an important role in transcription.
Insect Biochem. Mol. Biol.
23:81-90[CrossRef][Medline].
|
| 12.
|
Christensen, J.,
T. Storgaard,
B. Viuff,
B. Aasted, and S. Alexandersen.
1993.
Comparison of promoter activity in Aleutian mink diseas parvovirus, minute virus of mice, and canine parvovirus: possible role of weak promoters in the pathogenesis of Aleutian mink disease parvovirus infection.
J. Virol.
67:1877-1886[Abstract/Free Full Text].
|
| 13.
|
Clemens, D. L., and J. O. Carlson.
1989.
Regulated expression of the feline panleukopenia virus P38 promoter on extrachromosomal FPV/EBV chimeric plasmids.
J. Virol.
63:2737-2745[Abstract/Free Full Text].
|
| 14.
|
Cotmore, S. F.,
J. Christensen,
J. P. F. Nuesch, and P. Tattersall.
1995.
The NS1 polypeptide of the murine parvovirus minute virus of mice binds to DNA sequences containing the motif [ACCA]2-3.
J. Virol.
69:1652-1660[Abstract].
|
| 15.
|
Cotmore, S. F., and P. Tattersall.
1988.
The NS-1 polypeptide of minute virus of mice is covalently attached to the 5' termini of duplex replicative-form DNA and progeny single strands.
J. Virol.
62:851-860[Abstract/Free Full Text].
|
| 16.
|
Hanson, N. D., and S. L. Rhode, III.
1991.
Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification.
J. Virol.
65:4325-4333[Abstract/Free Full Text].
|
| 17.
|
Kimmick, M. W.,
B. N. Afanasiev,
B. J. Beaty, and J. O. Carlson.
1998.
Gene expression from the p7 promoter of Aedes densonucleosis virus.
J. Virol.
72:4364-4370[Abstract/Free Full Text].
|
| 18.
|
Kingston, R. E.,
P. Chomczynski, and N. Sacchi.
1995.
Guanidinium methods for total RNA preparation, p 4.2.1-4.2.8.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, 3rd ed. John Wiley & Sons, Inc., New York, N.Y.
|
| 19.
|
Kozak, M.
1986.
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
Cell
44:283-292[CrossRef][Medline].
|
| 20.
|
Kozak, M.
1999.
Initiation of translation in prokaryotes and eukaryotes.
Gene
234:187-208[CrossRef][Medline].
|
| 21.
|
Lorson, C.,
L. R. Burger,
M. Mouw, and D. J. Pintel.
1996.
Efficient transactivation of the minute virus of mice P38 promoter requires upstream binding of NS1.
J. Virol.
70:834-842[Abstract].
|
| 22.
|
Lorson, C.,
J. Pearson,
L. Burger, and D. J. Pintel.
1998.
An SP-1 site and TATA element are sufficient to support full transactivation by proximally bound NS1 protein of minute virus of mice.
Virology
240:326-337[CrossRef][Medline].
|
| 23.
|
O'Reilly, D. R.,
L. K. Miller, and V. A. Luckow.
1995.
Baculovirus expression vectors: a laboratory manual.
Oxford University Press, Inc., New York, N.Y.
|
| 24.
|
Ozawa, K.,
J. Ayub, and N. Young.
1988.
Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets.
J. Biol. Chem.
263:10922-10926[Abstract/Free Full Text].
|
| 25.
|
Pullen, S. S., and P. D. Freisen.
1995.
The CAGT motif functions as an initiator element during early transcription of the baculovirus transregulator ie-1.
J. Virol.
69:3573-3583.
|
| 26.
|
Rhode, S. L., III, and S. M. Richard.
1995.
Characterization of the trans-activation-responsive element of the parvovirus H-1 p38 promoter.
J. Virol.
61:2807-2815.
|
| 27.
|
Smale, S. T., and D. Baltimore.
1989.
The "initiator" as a transcription control element.
Cell
57:103-113[CrossRef][Medline].
|
| 28.
|
Smale, S. T.,
M. C. Schmidt,
A. J. Berk, and D. Baltimore.
1990.
Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID.
Biochemistry
87:4509-4513.
|
| 29.
| Tal, J. 1994. Densonucleosis viruses, Encyclopedia
of virology. p. 331-335. In R. G. Webster and A. Granoff (ed.), Academic Press, New York, N.Y.
|
| 30.
|
Vanacker, J.-M., and J. Rommelaere.
1995.
Non-structural proteins of autonomous parvoviruses from cellular effects to molecular mechanisms.
Semin. Virol.
6:291-297[CrossRef].
|
| 31.
|
Yamagishi, J.,
Y. Hu,
J. Zheng, and H. Bando.
1999.
Genome organization and mRNA structure of Periplaneta fuliginosa densovirus imply alternative splicing involvement in viral gene expression.
Arch. Virol.
144:2111-2124[CrossRef][Medline].
|
Journal of Virology, February 2001, p. 1325-1331, Vol. 75, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1325-1331.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhai, Y.-g., Lv, X.-j., Sun, X.-h., Fu, S.-h., Gong, Z.-d., Fen, Y., Tong, S.-x., Wang, Z.-x., Tang, Q., Attoui, H., Liang, G.-d.
(2008). Isolation and characterization of the full coding sequence of a novel densovirus from the mosquito Culex pipiens pallens. J. Gen. Virol.
89: 195-199
[Abstract]
[Full Text]
-
Wang, J., Zhang, J., Jiang, H., Liu, C., Yi, F., Hu, Y.
(2005). Nucleotide sequence and genomic organization of a newly isolated densovirus infecting Dendrolimus punctatus. J. Gen. Virol.
86: 2169-2173
[Abstract]
[Full Text]